List of articles with "Waltham"

Aerovate Cash Dividend

Aerovate Cash Dividend

United States Waltham Cash Dividend Aerovate Therapeutics Jade Biosciences
Foodservice Rewards Launch

Foodservice Rewards Launch

USA Waltham Buyers Edge Platform Foodservice Rewards Digital Procurement Network
Aerovate's Cash Dividend

Aerovate's Cash Dividend

United States Waltham Aerovate Therapeutics merger news Jade Biosciences
Spyre Therapeutics Grants

Spyre Therapeutics Grants

USA stock options Spyre Therapeutics Waltham IBD
Spyre Therapeutics SPY003

Spyre Therapeutics SPY003

United States Spyre Therapeutics Waltham SPY003 IL-23 Antibody
AI Caregiving Resource

AI Caregiving Resource

United States Multiple Sclerosis Waltham Accelerated Cure Project AI Caregiving Expert
Q32 Bio Update

Q32 Bio Update

United States Waltham Q32 Bio Bempikibart Alopecia Areata
Spyre Inducement Awards

Spyre Inducement Awards

USA Spyre Therapeutics Waltham SYRE IBD
Zixi's Innovations at NAB 2025

Zixi's Innovations at NAB 2025

USA Waltham Zixi NAB Show Live Video
SMBs: Embracing Tech & Social Media

SMBs: Embracing Tech & Social Media

United States Small Businesses Social Media Waltham Constant Contact
Alcresta Expands Leadership

Alcresta Expands Leadership

USA Waltham strategic growth RELiZORB Alcresta Therapeutics
Spyre Therapeutics Update

Spyre Therapeutics Update

USA Spyre Therapeutics Waltham SPY001 SPY002
AI in Sales Teams

AI in Sales Teams

USA Waltham AI Literacy Allego Sales Enablement
Embrace AI in Sales

Embrace AI in Sales

USA Waltham Allego AI Sales Sales Enablement
Spyre Therapeutics Advances

Spyre Therapeutics Advances

USA Spyre Therapeutics biotechnology Waltham IBD
New Leaders at Crescent

New Leaders at Crescent

USA Leadership oncology Waltham Crescent Biopharma
Industrial Insights Webinar

Industrial Insights Webinar

United States Waltham Webinar Series Simpson Gumpertz & Heger Industrial Insights
Innovations in Medical Foods

Innovations in Medical Foods

USA Waltham Solarea Bio Journa Bondia
Veralto Buys AQUAFIDES

Veralto Buys AQUAFIDES

United States Waltham Veralto AQUAFIDES Trojan Technologies
Support for Caregivers

Support for Caregivers

None Waltham MS Care Partners MS Resources Caregiver Support
Nanomosaic and BMS White Paper

Nanomosaic and BMS White Paper

USA Waltham Nanomosaic BMS AAV Technology
Q32 Bio Restructuring

Q32 Bio Restructuring

United States Waltham Q32 Bio Bempikibart Alopecia Areata
Spyre Grants Stock Options

Spyre Grants Stock Options

United States stock options Spyre Therapeutics Waltham Biotech Industry
Alegeus Empowers Health Wealth

Alegeus Empowers Health Wealth

USA Empower Waltham Health Solutions Alegeus
New CMO Hideo Makimura

New CMO Hideo Makimura

USA gene therapy Waltham Affinia Therapeutics Hideo Makimura
Syndax Inducement Grants

Syndax Inducement Grants

United States cancer therapies Waltham Syndax Pharmaceuticals SNDX
Buyers Edge Expands

Buyers Edge Expands

Waltham Switzerland Foodservice Buyers Edge MMC
Pazzanese Joins BEP

Pazzanese Joins BEP

USA Waltham Foodservice Buyers Edge Platform Jim Pazzanese
Jim Pazzanese Joins BEP

Jim Pazzanese Joins BEP

USA Waltham Foodservice Buyers Edge Platform Jim Pazzanese
FDA Approval for RELiZORB

FDA Approval for RELiZORB

United States FDA Approval Waltham RELiZORB Alcresta
MS Care Partners Resource

MS Care Partners Resource

USA Waltham MS Caregivers Accelerated Cure Project EMD Serono
Spyre's 2025 Highlights

Spyre's 2025 Highlights

USA Spyre Therapeutics Waltham IBD rheumatoid arthritis
Syndax's 2024 Highlights

Syndax's 2024 Highlights

USA Waltham Syndax Pharmaceuticals Revuforj Niktimvo
AFTX-201: New Hope for BAG3 DCM

AFTX-201: New Hope for BAG3 DCM

United States Waltham Affinia Therapeutics BAG3 DCM AFTX-201
Syndax Inducement Grants

Syndax Inducement Grants

United States Waltham Syndax Pharmaceuticals Revuforj Niktimvo
Spyre Joins Nasdaq

Spyre Joins Nasdaq

United States Spyre Therapeutics Waltham IBD Nasdaq Biotechnology
Granahan's Acclaim

Granahan's Acclaim

United States Waltham Money Management Granahan Investment Employee-Owned
Continuous Learning Impact

Continuous Learning Impact

USA Waltham Allego RAIN Group Sales Training
Continuous Learning in Sales

Continuous Learning in Sales

USA Waltham Allego RAIN Group Sales Training
Bempikibart Program Update

Bempikibart Program Update

USA Waltham Q32 Bio Bempikibart Alopecia Areata
Revuforj Clinical Results

Revuforj Clinical Results

USA Waltham Syndax Pharmaceuticals Revuforj AML Trials
Syndax Inducement Grants

Syndax Inducement Grants

United States Waltham Syndax Pharmaceuticals Revuforj Niktimvo
Spyre's New Inducement Awards

Spyre's New Inducement Awards

USA stock options Spyre Therapeutics Waltham IBD Treatments
Spyre Phase 1 Trials

Spyre Phase 1 Trials

USA Spyre Therapeutics Waltham Anti-TL1A Antibodies IBD Treatments
Syndax at Citi 2024

Syndax at Citi 2024

USA Waltham Syndax Pharmaceuticals avodart Revuforj
Spyre at HealthCONx

Spyre at HealthCONx

United States Spyre Therapeutics IBD treatment biotechnology Waltham

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.